| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
Ba/f3 FLT3 ITD |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
3.00 µM |
Ba/f3 FLT3 ITD |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
Ba/f3 FLT3 ITD |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
Ba/f3 FLT3 ITD |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
Ba/f3 FLT3 ITD |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
MV411 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
3.00 µM |
MV411 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
MV411 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
MV411 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
MV411 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability in presence of PKC412 |
ATP-dependent luminescence assay |
5.00 µM |
Ba/f3 FLT3 ITD |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability in presence of sunitinib |
ATP-dependent luminescence assay |
5.00 µM |
Ba/f3 FLT3 ITD |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
KU812 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
2.50 µM |
KU812 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
KU812 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
KU812 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
KU812 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
2.50 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
K562 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
2.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient1) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
1.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
2.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
5.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
7.50 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability |
ATP-dependent luminescence assay |
10.00 µM |
bone marrow mononuclear cells |
Homo sapiens (patient2) |
|
|
|
| Pimozide |
Influence on cell viability in presence of imatinib |
ATP-dependent luminescence assay |
5.00 µM |
KU812 |
Homo sapiens |
|
|
|
| Pimozide |
Influence on cell viability in presence of nilotinib |
ATP-dependent luminescence assay |
5.00 µM |
K562 |
Homo sapiens |
|
|
|
